XtalPi Holdings (FRA:V0I) Research & Development: €68.90 Mil (TTM As of Dec. 2025)


FRA:V0I XtalPi Holdings Ltd FRA:V0I
12 GF Score
Price €0.73
! 7 Warning Signs
View Full Analysis

What is XtalPi Holdings Research & Development?

XtalPi Holdings FRA:V0I -0.68% 12 Research & Development is €68.90 Mil as of Dec. 2025. GuruFocus rates FRA:V0I with a GF Score™ of 12/100. The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. XtalPi Holdings's Research & Development for the six months ended in Dec. 2025 was €42.15 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €68.90 Mil.

XtalPi Holdings  (FRA:V0I) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

XtalPi Holdings Research & Development Related Terms

XtalPi Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for XtalPi Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

XtalPi Holdings Research & Development Chart

XtalPi Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
29.54 48.60 61.73 54.86 69.02

XtalPi Holdings Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial 31.62 26.94 27.26 26.75 42.15
FRA:V0I
12GF Score
XtalPi Holdings Ltd FRA:V0I
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

XtalPi Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €68.90 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €68.90 Mil mean?
XtalPi Holdings (FRA:V0I) has a Research & Development of €68.90 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on XtalPi Holdings and its competitors.
Is XtalPi Holdings' Research & Development too high?
XtalPi Holdings' current Research & Development is €68.90 Mil. Overall, XtalPi Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does XtalPi Holdings' Research & Development compare to VEEV and BTSG?
XtalPi Holdings' Research & Development of €68.90 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on XtalPi Holdings and its competitors. XtalPi Holdings's current Research & Development is €68.90 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XtalPi Holdings stock overvalued right now?
XtalPi Holdings (FRA:V0I) has a current Research & Development of €68.90 Mil. The current Research & Development is €68.90 Mil. XtalPi Holdings' overall GF Score™ is 12/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For XtalPi Holdings (FRA:V0I), the current Research & Development is €68.90 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

XtalPi Holdings Business Description

Other Exchanges 02228:Hong Kong
Address No. 2 Hongliu Road, 3rd floor, Second Phase of the International, Biomedical Industrial Park, Futian District, Shenzhen, CHN
XtalPi Holdings Ltd is a research platform company powered by artificial intelligence (AI) and robotics. It is dedicated to driving intelligent and digital transformation in the life sciences and materials sciences sectors. The company combines quantum physics, AI, cloud computing, and large-scale robotics to provide research & development solutions, services, and products for pharmaceuticals, biotechnology, renewable energy, and materials industries globally. The company has a single segment that is intelligent robotics solutions and drug discovery solutions (including one-stop drug discovery solutions). The firm generates the majority of its revenue from Drug discovery solutions, and a smaller portion of revenue is derived from AI for Science intelligent solutions.
12GF Score

Get the complete analysis for FRA:V0I

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.73
Price